Document is current

Article History

Received: 27 November 2023

Accepted: 20 May 2024

First Online: 1 June 2024

Declarations

:

: NS reports lecture honoraria from Janssen, Abbvie et AstraZeneca all outside the submitted work. EB reports research funding, honorarium, speaker’s fees and travel expenses from Novartis, Astellas, Alexion, Jazz Pharmaceuticals, Gilead, MSD, Keocyt, Amgen, Beigen, Pierre Fabre, Pfizer, Celgene/BMS and Sanofi all outside the submitted work. RD reports research funding from Ligue contre le Cancer, Arthur Sachs, Monahan Foundation, Servier Foundation, Philippe Foundation, DCP AP-HP, honoraria from Novartis and Takeda, non-financial support from Kite Pharma / Gilead, all outside the submitted work. ZvdW reported honoraria from Janssen-Cilag, BMS, Sanofi. MM reports grants and lecture honoraria from Janssen, Sanofi, Maat Pharma and JAZZ Pharmaceuticals, lecture honoraria from Celgene, Amgen, BMS, Takeda, and Pfizer, grants from Roche, all outside the submitted work. FM reports lecture honoraria from Therakos/Mallinckrodt, BMS, MSD, Sanofi, Novartis, Aztra Zeneca and JAZZ Pharmaceuticals, all outside the submitted work. The other authors declare no competing financial interests.